Takaaki Higashihara, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Uremia | 2 | 2024 | 202 | 0.990 |
Why?
|
| Sarcopenia | 3 | 2024 | 378 | 0.880 |
Why?
|
| Clenbuterol | 1 | 2021 | 9 | 0.760 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 1 | 2021 | 109 | 0.700 |
Why?
|
| Glomerulonephritis, Membranoproliferative | 1 | 2019 | 41 | 0.670 |
Why?
|
| Prednisolone | 2 | 2017 | 324 | 0.650 |
Why?
|
| Colitis, Ischemic | 1 | 2018 | 32 | 0.610 |
Why?
|
| Muscular Atrophy | 1 | 2021 | 335 | 0.590 |
Why?
|
| Plasmapheresis | 1 | 2017 | 205 | 0.530 |
Why?
|
| Glomerulonephritis, IGA | 1 | 2017 | 61 | 0.530 |
Why?
|
| Pemphigus | 1 | 2017 | 107 | 0.520 |
Why?
|
| Behcet Syndrome | 1 | 2017 | 86 | 0.520 |
Why?
|
| Vasculitis | 1 | 2017 | 528 | 0.400 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2024 | 2306 | 0.390 |
Why?
|
| Diarrhea | 1 | 2018 | 1315 | 0.380 |
Why?
|
| Clostridium Infections | 1 | 2018 | 563 | 0.380 |
Why?
|
| Oxidative Stress | 1 | 2021 | 3140 | 0.330 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2024 | 552 | 0.320 |
Why?
|
| Renal Dialysis | 1 | 2018 | 1791 | 0.320 |
Why?
|
| Autoantibodies | 1 | 2017 | 2114 | 0.300 |
Why?
|
| Immunoglobulin G | 1 | 2019 | 4556 | 0.290 |
Why?
|
| Epithelial Cells | 1 | 2019 | 3684 | 0.280 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2019 | 4049 | 0.220 |
Why?
|
| Cell Proliferation | 1 | 2019 | 10433 | 0.220 |
Why?
|
| Indican | 1 | 2021 | 16 | 0.190 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2019 | 5388 | 0.180 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 1 | 2021 | 173 | 0.170 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2021 | 292 | 0.170 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2021 | 216 | 0.170 |
Why?
|
| Paraneoplastic Endocrine Syndromes | 1 | 2019 | 29 | 0.160 |
Why?
|
| Hexosaminidases | 1 | 2019 | 45 | 0.160 |
Why?
|
| Cell Size | 1 | 2021 | 626 | 0.160 |
Why?
|
| Muscle, Skeletal | 3 | 2024 | 4959 | 0.160 |
Why?
|
| Ascorbic Acid | 1 | 2021 | 657 | 0.140 |
Why?
|
| Glucocorticoids | 2 | 2017 | 2156 | 0.140 |
Why?
|
| Muscle Strength | 1 | 2021 | 638 | 0.130 |
Why?
|
| Filtration | 1 | 2017 | 227 | 0.130 |
Why?
|
| Tubulin Modulators | 1 | 2017 | 108 | 0.130 |
Why?
|
| Muscle Proteins | 1 | 2021 | 1160 | 0.130 |
Why?
|
| Colchicine | 1 | 2017 | 256 | 0.120 |
Why?
|
| Muscular Diseases | 1 | 2019 | 551 | 0.120 |
Why?
|
| Immunoglobulin A | 1 | 2017 | 992 | 0.110 |
Why?
|
| Exercise Therapy | 1 | 2020 | 938 | 0.110 |
Why?
|
| Reactive Oxygen Species | 1 | 2021 | 2144 | 0.100 |
Why?
|
| Hemangioma | 1 | 2018 | 724 | 0.100 |
Why?
|
| Dyslipidemias | 1 | 2019 | 871 | 0.100 |
Why?
|
| Drug Resistance | 1 | 2017 | 1592 | 0.090 |
Why?
|
| Lipid Metabolism | 1 | 2019 | 1893 | 0.090 |
Why?
|
| Interleukin-6 | 1 | 2019 | 3227 | 0.080 |
Why?
|
| Kidney Diseases | 1 | 2019 | 2100 | 0.080 |
Why?
|
| Mitochondria | 1 | 2021 | 3672 | 0.070 |
Why?
|
| Mice | 3 | 2024 | 81839 | 0.070 |
Why?
|
| Lymph Nodes | 1 | 2018 | 3456 | 0.070 |
Why?
|
| Heart Diseases | 1 | 2019 | 2818 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 10737 | 0.060 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2019 | 3186 | 0.050 |
Why?
|
| Aged | 4 | 2019 | 171219 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 1 | 2019 | 9237 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 22341 | 0.050 |
Why?
|
| Kidney Neoplasms | 1 | 2019 | 4282 | 0.050 |
Why?
|
| Animals | 3 | 2024 | 168800 | 0.050 |
Why?
|
| Kidney | 1 | 2017 | 7072 | 0.050 |
Why?
|
| Male | 5 | 2019 | 363935 | 0.040 |
Why?
|
| Humans | 9 | 2024 | 766117 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 15882 | 0.040 |
Why?
|
| Skin Neoplasms | 1 | 2018 | 5836 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2019 | 65219 | 0.030 |
Why?
|
| Immunoglobulins | 1 | 2018 | 853 | 0.030 |
Why?
|
| Nephrectomy | 1 | 2019 | 928 | 0.030 |
Why?
|
| Steroids | 1 | 2018 | 934 | 0.030 |
Why?
|
| Middle Aged | 2 | 2017 | 223083 | 0.030 |
Why?
|
| Female | 3 | 2021 | 396233 | 0.020 |
Why?
|
| Nutritional Status | 1 | 2020 | 1620 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2017 | 81565 | 0.020 |
Why?
|
| Biopsy | 1 | 2018 | 6768 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2018 | 11035 | 0.010 |
Why?
|
| Rats | 1 | 2020 | 23717 | 0.010 |
Why?
|
| Adult | 1 | 2017 | 223139 | 0.010 |
Why?
|
| Disease Progression | 1 | 2019 | 13616 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 59515 | 0.010 |
Why?
|